Is Boston Scientific in line for a private equity takeover? | Wall Street Beat

February 24, 2012 by MassDevice staff

Is hedge fund giant David Tepper's new stake in Boston Scientific an indication that it's ripe for a private equity buyout?; also, OTC lists Titan Medical; Burrill & Co. opens in Taiwan; MGT Capital plans reverse split to stay on NYSE; plus a Deals Roundup, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp